{"data":{"id":"us-ok/okla.-stat.-tit.-63-63-2-309","jurisdiction":"us-ok","citation":"Okla. Stat. tit. 63, § 63-2-309","heading":"Prescriptions","body":"A. 1. Except for dosages medically required for a period not\n\nto exceed forty-eight (48) hours which are administered by or on\n\ndirection of a practitioner, other than a pharmacist, or medication\n\ndispensed directly by a practitioner, other than a pharmacist, to an\n\nultimate user, no controlled dangerous substance included in\n\nSchedule II, which is a prescription drug as determined under\n\nregulation promulgated by the Board of Pharmacy, shall be dispensed\n\nwithout an electronic prescription of a practitioner; provided, that\n\nin emergency situations, as prescribed by the Board of Pharmacy by\n\nregulation, such drug may be dispensed upon oral prescription\n\nreduced promptly to writing and filed by the pharmacist in a manner\n\nto be prescribed by rules and regulations of the Director of the\n\nOklahoma State Bureau of Narcotics and Dangerous Drugs Control.\n\n2. Electronic prescribing shall be utilized for Schedules II,\n\nIII, IV and V, subject to the requirements set forth in 21 CFR,\n\nSection 1311 et seq.\n\n3. An electronic prescription with electronic signature may\n\nserve as an original prescription, subject to the requirements set\n\nforth in 21 CFR, Section 1311 et seq.\n\n4. Prescriptions shall be retained in conformity with the\n\nrequirements of this section and Section 2-307 of this title. No\n\nprescription for a Schedule II substance may be refilled.\n\n5. The electronic prescription requirement provided for in this\n\nsection shall not apply to prescriptions for controlled dangerous\n\nsubstances issued by any of the following:\n\na. a person licensed to practice veterinary medicine,\n\nb. a practitioner who experiences temporary technological\n\nor electrical failure or other extenuating\n\ncircumstance that prevents the prescription from being\n\ntransmitted electronically; provided, however, that\n\nthe practitioner documents the reason for this\n\nexception in the medical record of the patient,\n\nc. a practitioner, other than a pharmacist, who dispenses\n\ndirectly to an ultimate user,\n\nd. a practitioner who orders a controlled dangerous\n\nsubstance to be administered through an on-site\n\npharmacy in:\n\n(1) a hospital as defined in Section 1-701 of this\n\ntitle,\n\n(2) a nursing facility as defined in Section 1-1902\n\nof this title,\n\n(3) a hospice inpatient facility as defined in\n\nSection 1-860.2 of this title,\n\n(4) an outpatient dialysis facility,\n\n(5) a continuum of care facility as defined in\n\nSection 1-890.2 of this title, or\n\n(6) a penal institution listed in Section 509 of\n\nTitle 57 of the Oklahoma Statutes,\n\ne. a practitioner who orders a controlled dangerous\n\nsubstance to be administered through a hospice program\n\nincluding but not limited to a hospice program that\n\nprovides hospice services in the private residence of\n\na patient or in a long-term care facility where the\n\npatient resides. As used in this subparagraph,\n\n“hospice program” has the same meaning as provided by\n\nSection 1-860.2 of this title,\n\nf. a practitioner who writes a prescription to be\n\ndispensed by a pharmacy located on federal property,\n\nprovided the practitioner documents the reason for\n\nthis exception in the medical record of the patient,\n\ng. a practitioner that has received a waiver or extension\n\nfrom his or her licensing board,\n\nh. a practitioner who prescribes a controlled dangerous\n\nsubstance for a supply that when taken as prescribed\n\nwould be consumed within seventy-two (72) hours, or\n\ni. a practitioner who determines that an electronic\n\nprescription cannot be issued in a timely manner and\n\nthe condition of the patient is at risk.\n\n6. Electronic prescriptions may be utilized under the following\n\ncircumstances:\n\na. compounded prescriptions,\n\nb. compounded infusion prescriptions, or\n\nc. prescriptions issued under approved research\n\nprotocols.\n\n7. A pharmacist who receives a written, oral or facsimile\n\nprescription shall not be required to verify that the prescription\ntimely manner and\n\nthe condition of the patient is at risk.\n\n6. Electronic prescriptions may be utilized under the following\n\ncircumstances:\n\na. compounded prescriptions,\n\nb. compounded infusion prescriptions, or\n\nc. prescriptions issued under approved research\n\nprotocols.\n\n7. A pharmacist who receives a written, oral or facsimile\n\nprescription shall not be required to verify that the prescription\n\nfalls under one of the exceptions provided for in paragraph 6 of\n\nthis subsection. Pharmacists may continue to dispense medications\n\nfrom otherwise valid written, oral or facsimile prescriptions that\n\nare consistent with the provisions of this section.\n\n8. Practitioners shall indicate in the health record of a\n\npatient that an exception to the electronic prescription requirement\n\nwas utilized.\n\n9. All prescriptions issued pursuant to paragraph 5 and\n\nsubparagraph c of paragraph 6 of this subsection shall be on an\n\nofficial prescription form approved by the Oklahoma State Bureau of\n\nNarcotics and Dangerous Drugs Control if not issued electronically.\n\n10. a. Practitioners shall be registered with the Oklahoma\n\nState Bureau of Narcotics and Dangerous Drugs Control\n\nin order to purchase official prescription forms.\n\nSuch registration shall include, but not be limited\n\nto, the primary address and the address of each place\n\nof business to be imprinted on official prescription\n\nforms. Any change to a registered practitioner’s\n\nregistered address shall be promptly reported to the\n\npractitioner’s licensing board and the Bureau by the\n\npractitioner in a manner approved by the Bureau.\n\nb. Where the Bureau has revoked the registration of a\n\nregistered practitioner, the Bureau may revoke or\n\ncancel any official prescription forms in the\n\npossession of the registered practitioner. Any\n\nrevocation or any suspension shall require the\n\nregistered practitioner to return all unused official\n\nprescription forms to the Bureau within fifteen (15)\n\ncalendar days after the date of the written\n\nnotification.\n\nc. A practitioner that has had any license to practice\n\nterminated, revoked or suspended by a state or federal\n\nagency may, upon restoration of such license or\n\ncertificate, register with the Bureau.\n\n11. a. Official prescription forms shall be purchased at the\n\nexpense of the practitioner or the employer of the\n\npractitioner from a list of vendors approved by the\n\nBureau.\n\nb. Official prescription forms issued to a registered\n\npractitioner shall be imprinted with the primary\n\naddress and may include other addresses listed on the\n\nregistration of the practitioner to identify the place\n\nof origin. Such prescriptions shall be sent only to\n\nthe primary address of the registered practitioner.\n\nc. Official prescription forms of a registered\n\npractitioner shall be used only by the practitioner\n\ndesignated on the official prescription form.\n\nd. The Bureau may revoke or cancel official prescription\n\nforms in possession of registered practitioners when\n\nthe license of such practitioner is suspended,\n\nterminated or revoked.\n\ne. Official prescription forms of registered\n\npractitioners who are deceased or who no longer\n\nprescribe shall be returned to the Bureau at a\n\ndesignated address. If the registered practitioner is\n\ndeceased, it is the responsibility of the registered\n\npractitioner’s estate or lawful designee to return\n\nsuch forms.\n\nf. The Bureau may issue official prescription forms to\n\nemployees or agents of the Bureau and other government\n\nagencies for the purpose of preventing, identifying,\n\ninvestigating and prosecuting unacceptable or illegal\n\npractices by providers and other persons and assisting\n\nin the recovery of overpayments under any program\n\noperated by the state or paid for with state funds.\n\nSuch prescription forms shall be issued for this\n\npurpose only to individuals who are authorized to\nhe Bureau and other government\n\nagencies for the purpose of preventing, identifying,\n\ninvestigating and prosecuting unacceptable or illegal\n\npractices by providers and other persons and assisting\n\nin the recovery of overpayments under any program\n\noperated by the state or paid for with state funds.\n\nSuch prescription forms shall be issued for this\n\npurpose only to individuals who are authorized to\n\nconduct investigations on behalf of the Bureau or\n\nother government agencies as part of their official\n\nduties. Individuals and agencies receiving such\n\nprescription forms for this purpose shall provide\n\nappropriate assurances to the Bureau that adequate\n\nsafeguards and security measures are in place to\n\nprevent the use of such prescription forms for\n\nanything other than official government purposes.\n\n12. a. Adequate safeguards and security measures shall be\n\nundertaken by registered practitioners holding\n\nofficial prescription forms to assure against the\n\nloss, destruction, theft or unauthorized use of the\n\nforms. Registered practitioners shall maintain a\n\nsufficient but not excessive supply of such forms in\n\nreserve.\n\nb. Registered practitioners shall immediately notify the\n\nBureau, in a manner designated by the Bureau, upon\n\ntheir knowledge of the loss, destruction, theft or\n\nunauthorized use of any official prescription forms\n\nissued to them, as well as the failure to receive\n\nofficial prescription forms within a reasonable time\n\nafter ordering them from the Bureau.\n\nc. Registered practitioners shall immediately notify the\n\nBureau upon their knowledge of any diversion or\n\nsuspected diversion of drugs pursuant to the loss,\n\ntheft or unauthorized use of prescriptions.\n\nB. 1. Except for dosages medically required for a period not\n\nto exceed seventy-two (72) hours which are administered by or on\n\ndirection of a practitioner other than a pharmacist or medication\n\ndispensed directly by a practitioner, other than a pharmacist, to an\n\nultimate user, or the circumstances provided for in paragraphs 5 and\n\n6 of subsection A of this section, no controlled dangerous substance\n\nincluded in Schedule III or IV, which is a prescription drug as\n\ndetermined under regulation promulgated by the Board of Pharmacy,\n\nshall be dispensed without an electronic prescription.\n\n2. Any prescription for a controlled dangerous substance in\n\nSchedule III, IV or V may not be filled or refilled more than six\n\n(6) months after the date thereof or be refilled more than five\n\ntimes after the date of the prescription, unless renewed by the\n\npractitioner.\n\nC. Whenever it appears to the Director of the Oklahoma State\n\nBureau of Narcotics and Dangerous Drugs Control that a drug not\n\nconsidered to be a prescription drug under existing state law or\n\nregulation of the Board of Pharmacy should be so considered because\n\nof its abuse potential, the Director shall so advise the Board of\n\nPharmacy and furnish to the Board all available data relevant\n\nthereto.\n\nD. 1. “Prescription”, as used in this section, means a\n\nwritten, oral or electronic order by a practitioner to a pharmacist\n\nfor a controlled dangerous substance for a particular patient, which\n\nspecifies the date of its issue, and the full name and address of\n\nthe patient and, if the controlled dangerous substance is prescribed\n\nfor an animal, the species of the animal, the name and quantity of\n\nthe controlled dangerous substance prescribed, the directions for\n\nuse, the name and address of the owner of the animal and, if\n\nwritten, the signature of the practitioner. When electronically\n\nprescribed, the full name of the patient may include the name and\n\nspecies of the animal.\n\n2. “Registered practitioner”, as used in this section, means a\n\nlicensed practitioner duly registered with the Oklahoma State Bureau\n\nof Narcotics and Dangerous Drugs Control authorized to purchase\n\nofficial prescription forms.\nanimal and, if\n\nwritten, the signature of the practitioner. When electronically\n\nprescribed, the full name of the patient may include the name and\n\nspecies of the animal.\n\n2. “Registered practitioner”, as used in this section, means a\n\nlicensed practitioner duly registered with the Oklahoma State Bureau\n\nof Narcotics and Dangerous Drugs Control authorized to purchase\n\nofficial prescription forms.\n\nE. No person shall solicit, dispense, receive or deliver any\n\ncontrolled dangerous substance through the mail, unless the ultimate\n\nuser is personally known to the practitioner and circumstances\n\nclearly indicate such method of delivery is in the best interest of\n\nthe health and welfare of the ultimate user.","path":["OK Code","Title 63"],"source_url":"https://www.oklegislature.gov/OK_Statutes/CompleteTitles/os63.pdf","current_through":"2026-08-14","vintage":"open-us-law v2026.08, retrieved 2026-09-14","retrieved_at":"2026-09-14T18:32:36Z","sha256":"984f422757b4a4758bf46badda51eb4915de993331d83fb247745b9676673ba6","source_id":"us-ok","stale":false,"prev":"us-ok/okla.-stat.-tit.-63-63-2-308","next":"us-ok/okla.-stat.-tit.-63-63-2-309a"},"notice":"GroundRules: Original legal text. Not legal advice."}